Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-17

Clinical Trial Update: Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant tamoxifen for locally advanced breast cancer in a low/middle-income country has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Vanderbilt University | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2016-11-17